Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARTL | BMY | AMGN | GILD | VRTX |
| Company | Artelo Biosciences Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.3000 | 48.21 | 264.63 | 66.25 | 394.72 |
| High | 1.3900 | 49.05 | 269.38 | 66.83 | 396.98 |
| Low | 1.2800 | 48.12 | 260.68 | 66.16 | 391.25 |
| Last | 1.3200 | 48.93 | 268.93 | 66.76 | 394.28 |
| Change | +0.0400 | +0.63 | +6.18 | +0.60 | +0.80 |
| % Change | +3.13% | +1.30% | +2.35% | +0.91% | +0.20% |
| Volume | 6,100 | 10,303,900 | 3,380,300 | 10,656,899 | 1,342,100 |
| 20-Day Average Volume | 9,845 | 11,303,500 | 2,246,435 | 6,455,915 | 931,825 |
| Previous Close | 1.2800 | 48.30 | 262.75 | 66.16 | 393.48 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.4835 | 50.85 | 272.56 | 69.90 | 405.52 |
| 20-Day Raw Stochastic | 20.01% | 19.17% | 29.59% | 10.79% | 10.74% |
| 20-Day Relative Strength | 38.89% | 41.16% | 43.95% | 31.30% | 37.76% |
| Weighted Alpha | -34.40 | -28.90 | +7.67 | -24.32 | +15.95 |
| Today's Opinion | 56% Sell | 72% Sell | 56% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 56% Sell | 72% Sell | 56% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 32% Sell | 24% Sell | 8% Sell | 72% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -13.44% since 04/12/24 | +1.35% since 04/12/24 | +0.62% since 04/12/24 | -1.92% since 04/12/24 | -0.57% since 04/12/24 |
| Low | 1.2500 on 04/18/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 1.5100 on 04/15/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 402.49 on 04/15/24 |
| 1-Month | |||||
| %Chg | -12.00% since 03/19/24 | -5.54% since 03/19/24 | -1.03% since 03/19/24 | -9.06% since 03/19/24 | -5.04% since 03/19/24 |
| Low | 1.2500 on 04/18/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 1.7000 on 03/20/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -7.69% since 01/19/24 | -2.35% since 01/19/24 | -12.63% since 01/19/24 | -23.52% since 01/19/24 | -9.37% since 01/19/24 |
| Low | 1.2500 on 04/18/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 1.7500 on 02/14/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | -8.97% since 10/19/23 | -13.37% since 10/19/23 | -4.16% since 10/19/23 | -14.89% since 10/19/23 | +8.08% since 10/19/23 |
| Low | 1.1500 on 11/20/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 |
| High | 1.7500 on 02/14/24 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,131 | 97,892,464 | 140,812,720 | 82,374,304 | 101,698,464 |
| Shares Outstanding, K | 3,228 | 2,026,759 | 535,919 | 1,245,077 | 258,459 |
| Annual Sales | 0 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -9,290,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 0 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -3,070,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 1.45 | 0.39 | 0.58 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.99 on 03/25/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/09/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.38 | 14.16 | 9.96 | 29.25 |